Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by dt_coreon Mar 11, 2024 1:51pm
97 Views
Post# 35926794

RE:Proxy Firm ISS recommendation

RE:Proxy Firm ISS recommendation
Makes me wonder if THNK's board and management team are feeling nervous that investors might reject the Beedie offer. Let's be clear that management is likely much more in favour of the Beedie deal than one from another bidder (even at a higher price) as the former protects their jobs and the later likely results in their termination as part of creating synergies and/or as part of replacing the current management team with one that is competent. 
 
This is the last week for the go shop period. Time will tell if another bidder surfaces and/or Beedie sweetens the deal to get more shareholder support. While I still see a greater than 50% chance of another bid (which statistically is high compared to most go shop periods) I also recognize that managements lack of accountability in the past might also mean that SA has grossly exaggerated the company's pipeline, pipeline maturity, and business growth prospects. If no other bid surfaces that'll be evidence to me that management has indeed been misleading investors.
 
<< Previous
Bullboard Posts
Next >>